Algert Global LLC Ideaya Biosciences, Inc. Transaction History

Algert Global LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$34.37 - $43.46 $831,513 - $1.05 Million	-24,193 Reduced 65.62%	12,676 $445,000
Q1 2024 May 14, 2024	BUY	$34.2 - $47.13 $491,796 - $677,729	14,380 Added 63.94%	36,869 $1.62 Million
Q4 2023 Feb 14, 2024	SELL	$24.59 - $35.83 $494,996 - $721,257	-20,130 Reduced 47.23%	22,489 $800,000
Q3 2023 Nov 13, 2023	SELL	$21.07 - $29.77 $473,442 - $668,931	-22,470 Reduced 34.52%	42,619 $1.15 Million
Q2 2023 Aug 14, 2023	BUY	$13.33 - $25.53 $867,636 - $1.66 Million	65,089 New	65,089 $1.53 Million

216

80.8M

69K

20K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.28B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.